EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained ...
Shares of EYPT opened at $6.52 on Friday. EyePoint Pharmaceuticals has a one year low of $5.54 and a one year high of $23.97. The company has a 50-day simple moving average of $7.22 and a two ...
For the quarter ended December 2024, EyePoint Pharmaceuticals (EYPT) reported revenue of $11.59 million, down 17.4% over the same period last year. EPS came in at -$0.64, compared to -$0.33 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback